Saturday 17 October 2026
Export SGHT’s income statement to Excel — free account
Sight Sciences, Inc.
SGHT Healthcare Medical Devices
Sight Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $77.4 million, down 3.13% from fiscal 2024. In the quarter to June 2026, revenue grew 19.6%, EPS grew 65.2%, free cash flow grew 26.7% and total debt rose 2.40%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
8.28
0.52
−5.91%
Follow SGHT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 5 | 5 | 5 | 5 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
0.83 | (0.98) | 1.20 | 5.16 | 5.79 | — | — | — | — |
P/S ratio |
5.35 | 2.28 | 3.06 | 8.26 | 9.59 | 8.29 | 8.29 | 8.29 | — |
Altman Z″-Score (non-manufacturers) |
(5.95) | (2.91) | 0.57 | 2.77 | 8.22 | (2.05) | (12.64) | (32.97) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(3.04) | (3.89) | (2.55) | (2.11) | (2.13) | (1.66) | (1.02) | — | — |
P/Operating CF |
(226.35) | (52.76) | (38.25) | (38.03) | (43.81) | (25.89) | (25.89) | (25.89) | — |
P/B ratio |
6.47 | 2.09 | 2.06 | 3.68 | 2.02 | 0.00 | 0.00 | 0.00 | — |
Price to Tangible BV |
6.47 | 2.09 | 2.06 | 3.68 | 2.02 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
4.71 | 1.30 | 1.77 | 6.15 | 4.95 | 8.21 | 8.21 | 8.21 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(12.26) | (4.64) | (3.05) | (5.78) | (4.61) | (7.51) | (7.51) | (7.51) | — |
EV/FCF |
(12.11) | (4.56) | (3.00) | (5.70) | (4.54) | (7.37) | (7.37) | (7.37) | — |
Quick Ratio |
9.22 | 8.48 | 12.44 | 11.23 | 19.95 | 7.18 | 3.45 | 2.09 | — |
Current Ratio |
10.22 | 9.04 | 13.29 | 11.77 | 20.52 | 7.58 | 3.82 | 2.47 | — |
Net Debt/EBITDA |
1.45 | 1.65 | 1.86 | 1.82 | 4.54 | 0.94 | (2.41) | (2.10) | — |
Debt/Assets |
34.95% | 27.55% | 20.36% | 16.12% | 11.84% | 44.43% | 254.37% | 421.95% | 0.00% |
Debt/Equity |
0.63 | 0.45 | 0.28 | 0.21 | 0.14 | (0.36) | (1.43) | (1.18) | — |
Asset Turnover |
0.60 | 0.52 | 0.43 | 0.29 | 0.28 | 0.53 | 1.20 | 1.86 | — |
Operating CF/Net income |
0.77 | 0.43 | 0.85 | 0.88 | 0.83 | 0.93 | 0.97 | 1.01 | — |
Capex/Depreciation |
(0.16) | (0.26) | (0.64) | (0.71) | (0.61) | (0.84) | 0.00 | 0.00 | — |
Interest Coverage |
(7.21) | (10.84) | (10.59) | (18.80) | (11.79) | (13.39) | (22.52) | (28,594.00) | — |
| (50.74%) | (49.59%) | (39.64%) | (43.98%) | (87.90%) | 48.34% | 61.85% | 34.17% | — | |
| (29.77%) | (33.29%) | (29.26%) | (34.97%) | (35.67%) | (67.01%) | (133.23%) | (353.10%) | — | |
ROIC |
(188.86%) | (484.25%) | (223.54%) | (556.90%) | (701.56%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(37.19%) | (40.92%) | (36.48%) | (44.59%) | (23.76%) | (55.43%) | (111.33%) | (278.23%) | — |
Average Days of Receivables |
45.98 | 49.29 | 64.34 | 77.51 | 64.93 | 70.82 | 64.00 | 87.98 | — |
Research and Development Expense of Revenue |
18.88% | 22.53% | 21.66% | 32.05% | 31.93% | 32.11% | 34.80% | 72.06% | — |
Selling, General and Administrative Expense of Revenue |
115.25% | 126.24% | 134.34% | 168.32% | 155.63% | 151.03% | 140.14% | 186.76% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
16.87% | 21.38% | 17.99% | 18.17% | 10.38% | 1.80% | 0.00% | 0.00% | — |
Graham Net Nets |
0.15 | 0.46 | 0.47 | 0.27 | 0.49 | (0.38) | (0.38) | (0.38) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.52 | 0.00 | 0.00 | — |
Earnings Yield |
(9.46%) | (28.30%) | (22.35%) | (14.61%) | (22.12%) | (12.41%) | (12.41%) | (12.41%) | — |
Free Cash Flow Yield |
(7.27%) | (12.46%) | (19.34%) | (13.05%) | (11.36%) | (13.44%) | (13.44%) | (13.44%) | — |
Revenue per Share |
1.48 | 1.59 | 1.67 | 1.49 | 1.83 | 2.95 | 0.50 | 0.16 | — |
Operating CF per Share |
(0.57) | (0.45) | (0.97) | (1.59) | (1.97) | (3.44) | (0.53) | (0.31) | — |
Capex per Share |
0.00 | (0.01) | (0.02) | (0.02) | (0.03) | (0.10) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(0.57) | (0.45) | (0.99) | (1.61) | (2.00) | (3.54) | (0.53) | (0.31) | — |
Cash per Share |
1.76 | 2.40 | 2.84 | 3.87 | 9.75 | 6.57 | 0.45 | 0.09 | — |
Shareholders Equity per Share |
1.23 | 1.75 | 2.47 | 3.35 | 8.68 | (9.50) | (1.17) | (0.62) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.23 | 1.75 | 2.47 | 3.35 | 8.68 | (9.50) | (1.17) | (0.62) | — |
Free Cash Flow |
(29.92) | (22.74) | (47.97) | (76.93) | (53.35) | (33.13) | (25.00) | (14.47) | — |
Working Capital |
101.71 | 124.31 | 150.62 | 191.86 | 263.53 | 61.32 | 20.67 | 4.27 | — |
Capital Expenditures |
(0.22) | (0.38) | (0.79) | (0.97) | (0.81) | (0.95) | (0.67) | (0.57) | — |
Net Current Asset Value |
61.38 | 84.46 | 116.44 | 156.68 | 228.96 | (91.02) | (57.42) | (29.89) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.00 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.89 | 0.93 | 0.75 | 0.87 | 0.92 | 0.89 | 0.17 | 0.07 | — |
Cash ROIC |
(15.25%) | (9.20%) | (16.41%) | (20.28%) | (10.14%) | (660.95%) | (55.86%) | (153.45%) | — |
Accounts Receivable Turnover |
7.54 | 6.37 | 5.51 | 5.98 | 6.96 | 5.85 | 7.90 | 2.55 | — |
Accounts Payable Turnover |
7.05 | 6.77 | 5.38 | 4.09 | 3.13 | 4.12 | 3.12 | 1.11 | — |
Inventory Turnover |
1.52 | 1.63 | 1.70 | 2.58 | 2.84 | 3.80 | 4.79 | 1.71 | — |
Average Days of Payables |
45.83 | 53.30 | 53.18 | 79.37 | 142.06 | 85.53 | 129.12 | 293.34 | — |
Days of Inventory on Hand |
265.02 | 199.35 | 241.13 | 180.54 | 147.31 | 102.97 | 125.16 | 75.87 | — |
Average Receivables |
10.27 | 12.54 | 14.72 | 11.93 | 7.04 | 4.73 | 2.95 | 2.95 | — |
Average Payables |
1.52 | 1.71 | 2.21 | 3.02 | 2.75 | 2.24 | 2.10 | 2.10 | — |
Average Inventory |
7.05 | 7.09 | 6.98 | 4.79 | 3.04 | 2.42 | 1.37 | 1.37 | — |
Average Assets |
129.07 | 154.75 | 189.86 | 246.63 | 176.50 | 51.77 | 19.42 | 4.05 | — |
Average Common Equity |
75.73 | 103.87 | 140.15 | 196.09 | 71.63 | (71.77) | (41.82) | (41.82) | — |
Columns are period end dates